Kim Blakely, Ph.D.

Affiliations: 
2012 University of Toronto, Toronto, ON, Canada 
Area:
Molecular Biology
Google:
"Kim Blakely"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Jason Moffat grad student 2012 University of Toronto
 (Development and application of a novel method to detect mammalian protein-protein interactions.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Vojvodic M, Hansford LM, Morozova O, et al. (2013) A phosphoproteomics approach to identify candidate kinase inhibitor pathway targets in lymphoma-like primary cell lines. Current Drug Discovery Technologies. 10: 283-304
Mak AB, Blakely KM, Williams RA, et al. (2011) CD133 protein N-glycosylation processing contributes to cell surface recognition of the primitive cell marker AC133 epitope. The Journal of Biological Chemistry. 286: 41046-56
Blakely K, Ketela T, Moffat J. (2011) Pooled lentiviral shRNA screening for functional genomics in mammalian cells. Methods in Molecular Biology (Clifton, N.J.). 781: 161-82
Ketela T, Heisler LE, Brown KR, et al. (2011) A comprehensive platform for highly multiplexed mammalian functional genetic screens. Bmc Genomics. 12: 213
Smith KM, Datti A, Fujitani M, et al. (2010) Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens. Embo Molecular Medicine. 2: 371-84
Morozova O, Vojvodic M, Grinshtein N, et al. (2010) System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 4572-82
Mak AB, Ni Z, Hewel JA, et al. (2010) A lentiviral functional proteomics approach identifies chromatin remodeling complexes important for the induction of pluripotency. Molecular & Cellular Proteomics : McP. 9: 811-23
Hansford LM, Morozova O, Lipman T, et al. (2010) Abstract 12: Metastatic neuroblastoma cancer stem cells display a mixed phenotype of tumor and niche origin required for survival Cancer Research. 70: 12-12
See more...